Helen of Troy (HELE) delivered a large earnings beat for its fiscal second quarter. Adjusted EPS of $0.79 topped the $0.51 consensus by 43.6% and cleared the $0.55 Earnings Whisper number. Revenue of $440.93 million rose 2.1% year over year and missed consensus by just 0.1%. Earnings Whispers calculates earnings growth of 295.0%; the company's own adjusted comparison shows a 33.9% increase from $0.59. On a GAAP basis, the company swung to a $0.19 profit from a $13.44 loss a year ago that was dominated by impairment charges. The central tension is this: the raised full-year outlook is almost entirely a tariff-refund and balance-sheet story, while the underlying business guidance was essentially held and the top line is barely growing.
The quality of the beat deserves scrutiny, though it holds up better than a skeptic might expect. Gross margin jumped 800 basis points to 52.2%, and roughly 560 of those points came from tariff refunds net of higher tariff costs. Of the $26.9 million in gross refunds recognized, about $23 million was immediately reinvested, so the net benefit was only about $4.0 million pre-tax, or roughly $0.12 per share. Management said adjusted EPS and EBITDA beat its own expectations even without that net benefit. A second adjustment matters too. Starting this quarter, the company excludes divestiture litigation costs tied to the 2021 sale of its personal care business, a $0.17 per-share add-back that did not exist in prior adjusted results. Working the other way, the adjusted tax rate was an elevated 34.1% because of loss-making jurisdictions. Adjusted EBITDA rose to $49.4 million from $36.2 million, a 280-basis-point margin improvement. The SG&A ratio climbed 540 basis points to 46.4% as refunds were channeled into personnel, marketing, packaging and legal costs.
Beneath the consolidated figure, the two segments are moving in opposite directions. Home & Outdoor grew 9.2%, with every brand up, close to Q1's 9.5% pace. International growth improved to 3.7% from 1.1% in Q1. Beauty & Wellness, however, fell 4.5% after growing roughly 7% in Q1. Hair appliances, prestige hair care and PUR water filtration all declined, and only heaters, thermometers and nail care offset the weakness. Management pointed to noticeably better North American point-of-sale trends in Beauty & Wellness and appointed a new segment leader. It also flagged a possible Revlon price recalibration and continued softness in prestige beauty.
The guidance raise is substantial on paper. Consolidated adjusted EPS moved to $3.60-$4.15 from $3.25-$3.75, adjusted EBITDA to $203-$210 million from $190-$197 million, and free cash flow to $120-$140 million from $85-$100 million. Strip out the refunds, which now total about $80.5 million with 83%-88% slated for reinvestment, and the picture is flatter. Base-business EBITDA was held at $193-$196 million, and base EPS was merely narrowed to $3.30-$3.70. Sales guidance was narrowed to $1.768-$1.822 billion with a slightly lower midpoint. Home & Outdoor was cut to $851-$876 million because of beverageware saturation, promotions and a channel inventory correction at Hydro Flask. The illness-season assumption was also lowered, and management expects reinvestment timing to compress Q4 EPS.
The balance sheet is the clearest improvement. Net leverage fell to 3.0x from about 3.5x in Q1 and 3.9x at fiscal year-end, and the year-end target is now 2.7x or lower versus 3.2x originally. Debt is down $221 million year over year to $673 million, and inventory is down $49 million. Catalysts include the August launch of the OXO pet line, new Osprey luggage, PUR contaminant certifications and a new Australian distributor.
The market's verdict was abrupt. Shares set a 52-week high of $31.98 on report day and then fell to the inter-earnings low of $26.20 in the same session. The stock now sits at $26.51, 17.1% below that peak and 0.7% below where it opened after the July report. Shares remain 14.1% above the 200-day moving average, but the report-day reversal erased the quarter's gains. Investor sentiment stayed positive but weakened, slipping to 0.09 from 0.18. The trend readings are mixed, with price and momentum neutral and AVWAP negative.
The bottom line is that Helen of Troy produced a genuine operating beat and a meaningfully stronger balance sheet, but the headline guidance raise is largely refund-funded. The core business outlook was held rather than lifted, Hydro Flask is a new soft spot, and Beauty & Wellness slipped back into decline. Investors sold the spike, and the next leg likely depends on proving organic growth once the refunds are spent.